Single answer

Is AxoGen Inc (AXGN) a buy or sell?

4starter turns market data into one clear verdict you can act on.

Buy
$32.73
-0.720 (-2.15%)
Quote updated: 2025-12-30 21:00 UTC
Signal strength
80/100
Trend today
-2.15%
Down today
Volume vs avg
Not available
Target gap
14.36%
above current price
Signal updated
2025-12-30 16:32 UTC
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices
Add to watchlist

Create a free account to save tickers and track your signals.

Log in to turn on watchlist alerts.

What is the conclusion?

Right now our advanced algorithms say:

YES

$1 invested is now $1.38 or 38.17%

(In 18 weeks 6 days 16 hours 11 minutes and 1 second .)

Do analysts agree?

We compare consensus targets with today's price.

YES

Consensus target for AxoGen Inc is $37.43, which is $4.70 (14.36%) above the current price today's price.

Low target: $34.00 | High target: $40.00

Company snapshot

A quick overview of the business and its public profile.

AxoGen Inc together with its subsidiaries develops and markets surgical solutions for physical damage or transection to peripheral nerves The companys products include Avance Nerve Graft a biologically active offtheshelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site AxoGuard Nerve Connector a porcine submucosa extracellular matrix ECM coaptation aid for tensionless repair of severed peripheral nerves and AxoGuard Nerve Protector a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves as well as reinforces the nerve reconstruction while preventing soft tissue attachments Its products also comprise Axoguard Nerve Cap a porcine submucosa ECM product that is used to protect a peripheral nerve end as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma and Avive Soft Tissue Membrane a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed In addition the company offers AxoTouch two point discriminator a tool that is used for measuring the innervation density of surface area of the skin It provides its products to hospitals surgery centers and military hospitals plastic reconstructive surgeons orthopedic and plastic hand surgeons and various oral and maxillofacial surgeons in the United States Canada Germany the United Kingdom and other European countries South Korea and internationally AxoGen Inc is headquartered in Alachua Florida

Website: https://www.axogeninc.com

Rates and inflation backdrop

US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.

Inflation sensitivity

Debt ratio: 0.09. Cash flow to debt ratio: 0.33. Net profit margin: -0.98%. Inflation risk score: low (0.45/1).

Dividend history check

Yes, AxoGen Inc pays dividends. Last payment was 2010-02-12 for holders on 2010-01-27. Over 3 payments between 1992 and 2010, total $1.102 with an average of $0.367 per share. Last dividend was $1.000.

Trading liquidity

Yes, the average daily trading liquidity for AxoGen Inc is $20.4M. You should therefore be able to get in and out of your positions relatively fast.

10-year return check

On AxoGen Inc, 2015-12-31 had a stock price of $5.00. If you invested back then, your return now would be a profit of $27.73 per share or 554.60%.

Why this answer

We combine price momentum, volatility, and trend signals to simplify the decision to one word.

1

Signal engine scans price, trend, and momentum indicators.

2

Targets and sentiment are checked against the live quote.

3

We keep the output simple: buy, sell, or hold.

Analyst consensus

How Wall Street targets compare to today's price.

$37.43
$4.70 (14.36%) above the current price
Range: $34.00 - $40.00

FAQ

Today's 4starter signal is Buy. That means the current data favors upside over downside.

Quotes and targets refresh throughout the trading day, with the latest timestamp shown on the page.

It blends momentum, trend, and volatility indicators into a single decision-oriented verdict.